rs281864919
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM5PP3_StrongPP5_Very_Strong
The NM_000171.4(GLRA1):c.1259G>A(p.Arg420His) variant causes a missense change. The variant allele was found at a frequency of 0.0000137 in 1,461,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R420C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000171.4 missense
Scores
Clinical Significance
Conservation
Publications
- hyperekplexia 1Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- hereditary hyperekplexiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GLRA1 | NM_000171.4 | c.1259G>A | p.Arg420His | missense_variant | Exon 9 of 9 | ENST00000274576.9 | NP_000162.2 | |
| GLRA1 | NM_001146040.2 | c.1283G>A | p.Arg428His | missense_variant | Exon 9 of 9 | NP_001139512.1 | ||
| GLRA1 | NM_001292000.2 | c.1010G>A | p.Arg337His | missense_variant | Exon 8 of 8 | NP_001278929.1 | ||
| GLRA1 | XM_047417105.1 | c.1307G>A | p.Arg436His | missense_variant | Exon 9 of 9 | XP_047273061.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GLRA1 | ENST00000274576.9 | c.1259G>A | p.Arg420His | missense_variant | Exon 9 of 9 | 1 | NM_000171.4 | ENSP00000274576.5 | ||
| GLRA1 | ENST00000455880.2 | c.1283G>A | p.Arg428His | missense_variant | Exon 9 of 9 | 1 | ENSP00000411593.2 | |||
| GLRA1 | ENST00000462581.6 | n.*1017G>A | non_coding_transcript_exon_variant | Exon 8 of 8 | 1 | ENSP00000430595.1 | ||||
| GLRA1 | ENST00000462581.6 | n.*1017G>A | 3_prime_UTR_variant | Exon 8 of 8 | 1 | ENSP00000430595.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.0000477 AC: 12AN: 251342 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461478Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727080 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Observed in apparent homozygous state or with a variant on the opposite allele (in trans) in several unrelated patients with features of GLRA1-related hyperekplexia referred for genetic testing at GeneDx and in published literature (PMID: 25036534, 10514101, 20631190); Functional studies demonstrate that R420H results in impaired trafficking causing deficiency of cell surface targeting and reduced cell surface expression (PMID: 29440552, 19732286, 12169101, 20631190); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as R392H; This variant is associated with the following publications: (PMID: 24405574, 19732286, 12169101, 20631190, 10514101, 28122427, 31589614, 31440721, 11389164, 21109219, 12404628, 25356525, 12427512, 25036534, 29440552, 34926809)
PS3, PP3, PM2, PM3
Hereditary hyperekplexia Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 420 of the GLRA1 protein (p.Arg420His). This variant is present in population databases (rs281864919, gnomAD 0.03%). This missense change has been observed in individuals with autosomal recessive hyperekplexia (PMID: 10514101, 20631190, 25036534). It has also been observed to segregate with disease in related individuals. This variant is also known as p.R392H. ClinVar contains an entry for this variant (Variation ID: 242680). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt GLRA1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects GLRA1 function (PMID: 12169101, 19732286, 20631190). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at